| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
May 20, 2009 |
|
|
| |
|
|
| |
|
|
|
Terrapinn, London
2009-11-18
The World Drug Targets Congress 2009 helps companies tackle the critical scientific and commercial challenges and take hold of the opportunities associated with effective identification and validation of new and existing drug targets.
Here are just some critical issues facing the industry: - Increasing the rate of innovation of pharmaceutical R&D departments is central to the survival of big pharmaceutical companies and biotech.
- Identification of new targets is a time consuming and expensive process, and a challenge which companies have recently struggled to meet. Help is needed.
- Target validation involving rigorous evaluation to demonstrate that interaction with the target will have the desired therapeutic effect.
Download the brochure to find out more: http://www.terrapinn.com/template/master/docdl.aspx?txtEID=3191
|
|
|
|
|
|
|
|
Organized by:
|
|
Terrapinn |
|
|
Invited Speakers:
|
|
TBC
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
200/11/01
|
|
|
|
|
|
|
|
Registration:
|
|
Please register your place here: https://secure.terrapinn.com/V5/rCalc.aspx?E=3191
|
|
|
E-mail:
|
|
marcia.ardila@terrapinn.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|